OTC : BRNHF

Broncus Holding Corporation

$0.08 USD

$0 (0.0%)

Volume
10K
Average Volume
9K
Market Capitalization
$42.13M
P/E Ratio
-2.21
Dividend Yield
0.00%
Price Target
Year High
$0.08
Year Low
$0.08
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$22.70
Company Overview

OTC

Hong Xu

Medical - Devices

Healthcare

BRNHF

200

CN

USD

https://www.broncus.com

+852 3900 0888

G1609T102

N/A

Liquidity Metrics

0.00

22.70

22.04

5.39

0.00

Sales & Valuation

$174.26K

246.70

0.26

-4.28

-0.02

Profitability

-$0.037

-$17.9M

-10273.01%

-10272.44%

-11.54%

-11.47%

P/E Metrics

-2.21

0.12

0.12

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

-0.13

4/9

$128.46M

$156.13M

$6.17M

-$39.67M

Key Metrics (TTM)

$13.09M

75.10

-0.58

22.70

-11.54%

-16.26%

-43.30%

-22.30%

7146 days

Company Executives
Name Title
Feng Yao Sr. Accountant
Hong Xu Chairman of the Board & Chief Executive Officer
Thomas Keast Vice President, Operation Director & Scientist in resident
Elaine Lu Director of Finance & Administration
Ka Yan Suen Company Secretary
Poll Results

No votes yet today — be the first to share your view!

About Broncus Holding Corporation (OTC:BRNHF) Stock

Broncus Holding Corporation is a medical technology enterprise dedicated to advancing interventional pulmonology through the development of specialized products. Its operational reach extends across key markets including Mainland China, the European Union, the United States, and other international regions. The company's product portfolio is broadly categorized into navigation and treatment solutions. Navigation offerings include: LungPoint Virtual Bronchoscopic Navigation: A sophisticated, computer-assisted software system that utilizes imaging for virtual bronchoscopic guidance. LungPoint Plus: This system provides real-time navigational assistance within the airways, crucial for lung biopsies and various other pulmonological procedures. LungPro: A virtual bronchoscopic navigation tool t ... hat facilitates three-dimensional, real-time guided transbronchial needle aspiration and features proprietary parenchymal navigation capabilities. Its comprehensive suite of treatment products comprises: InterVapor: A targeted bronchoscopic thermal vapor ablation method designed to treat diseased, hyper-inflated lung segments. RF Generator + RF Ablation Catheter: A radiofrequency ablation system specifically engineered for use with a disposable lung radiofrequency ablation catheter, targeting lung cancer. H-Marker: A specialized marker for pulmonary surgical applications. Furthermore, Broncus provides essential procedural accessories and tools such as: BioStarNeedle: A single-use, ultrasound-guided aspiration needle for efficiently collecting tissue samples. FleXNeedle: A versatile biopsy needle adaptable for multiple purposes. Archimedes Sheath: A sterile, single-use flexible tube that establishes a working channel during bronchoscopic interventions. Archimedes Dilation Balloon: A sterile, single-use flexible tube equipped with a balloon at its tip, inserted via a bronchoscope or sheath to dilate targeted lung tissue within the bronchial tree. Steerable Sheath: Featuring a steerable adjustment handle and a working channel for enhanced maneuverability. Broncus Holding Corporation was established in 2012 and maintains its corporate headquarters in Hangzhou, China.

Frequently Asked Questions

What is the current Broncus Holding Corporation (BRNHF) stock price?

Broncus Holding Corporation(OTC:BRNHF) stock price is $0.08 in the last trading session. During the trading session, BRNHF stock reached the peak price of $0.08 while $0.08 was the lowest point it dropped to. The percentage change in BRNHF stock occurred in the recent session was 0.0% while the dollar amount for the price change in BRNHF stock was $0.

BRNHF's industry and sector of operation?

The OTC listed BRNHF is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of BRNHF?

Feng Yao | Sr. Accountant
Hong Xu | Chairman of the Board & Chief Executive Officer
Thomas Keast | Vice President, Operation Director & Scientist in resident
Elaine Lu | Director of Finance & Administration
Ka Yan Suen | Company Secretary

How many employees does BRNHF have?

Number of BRNHF employees currently stands at 200. BRNHF operates from Room 801, Building 8, Hangzhou, None None, CN.

Link for BRNHF official website?

Official Website of BRNHF is: https://www.broncus.com

How do I contact BRNHF?

BRNHF could be contacted at phone #+852 3900 0888 and can also be accessed through its website. BRNHF operates from Room 801, Building 8, Hangzhou, None None, CN.

How many shares of BRNHF are traded daily?

The average number of BRNHF shares traded daily for last 3 months was 9K.

What is the market cap of BRNHF currently?

The market value of BRNHF currently stands at $42.13M with its latest stock price at $0.08